Get the Stockscreener App
20.86
2.81%
0.57
After Hours:
20.70
-0.16
-0.77%
Kalvista Pharmaceuticals Inc Stock (KALV) Forecast
The Kalvista Pharmaceuticals Inc (KALV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $23.90, representing a +14.56% increase from the current price of $20.86. The highest analyst price target is $29.20, and the lowest is $18.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KALV Price Target
Average 15.74
(-24.53% Downside)
Is Kalvista Pharmaceuticals Inc (KALV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 65.22 | Neutral |
| STOCH(9,6) | 55.10 | Neutral |
| STOCHRSI(14) | 78.35 | Neutral |
| MACD(12,26) | 0.9543 | Buy |
| ADX(14) | 27.91 | Buy |
| William %R | -9.147 | Sell |
| CCI(14) | 39.88 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
19.93
Buy
|
19.79
Buy
|
| MA20 |
18.76
Buy
|
19.05
Buy
|
| MA50 |
17.09
Buy
|
17.64
Buy
|
| MA100 |
16.24
Buy
|
16.38
Buy
|
| MA200 |
14.63
Buy
|
14.84
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, KALV could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on KALV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 65.22 indicates that KALV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.1 indicates that KALV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.35 indicates that KALV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.91 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 39.88 indicates that KALV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term KALV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kalvista Pharmaceuticals Inc financial reports and earnings history, Kalvista Pharmaceuticals Inc (KALV) stock could reach $5.1459 by 2030, $14.85 by 2040 and $29.57 by 2050. See the projected annual prices until 2050 of the Kalvista Pharmaceuticals Inc stock below:
- Kalvista Pharmaceuticals Inc (KALV) is expected to reach an average price of $5.6064 in 2035, with a high prediction of $5.5712 and a low estimate of $5.7509. This indicates an $-73.12% rise from the last recorded price of $20.86.
- Kalvista Pharmaceuticals Inc (KALV) stock is projected to chart a bullish course in 2040, with an average price target of $14.39, representing an $-31.01% surge from its current level. The forecast ranges from a conservative $15.05 to a sky-high $14.85.
- Our analysts predict Kalvista Pharmaceuticals Inc (KALV) to jump 36.96% by 2045, soaring from $19.81 to an average price of $28.57, potentially reaching $18.79. While $19.81 is the low estimate, the potential upside is significant.
- Kalvista Pharmaceuticals Inc (KALV) stock is expected to climb by 2050, reaching an average of $29.96, a $43.61% jump from its current level. However, a wide range of estimates exists, with high and low targets of $29.57 and $30.22, respectively, highlighting the market's uncertainty.
Kalvista Pharmaceuticals Inc Stock (KALV) Year by Year Forecast
Kalvista Pharmaceuticals Inc Stock (KALV) Price Forecast for 2026
The predicted value for Kalvista Pharmaceuticals Inc (KALV) in 2026 is set at an average of $19.10. Estimates vary from a peak of $34.45 to a trough of $3.7537, indicating an -8.44% surge from the present price of $20.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $21.94 | $18.59 | $29.20 | +5.17% |
| June, 2026 | $15.80 | $14.85 | $22.98 | -24.27% |
| July, 2026 | $15.82 | $10.07 | $16.36 | -24.16% |
| August, 2026 | $18.59 | $13.85 | $20.10 | -10.88% |
| September, 2026 | $12.92 | $12.26 | $20.57 | -38.06% |
| October, 2026 | $10.01 | $9.5412 | $13.72 | -52.01% |
| November, 2026 | $10.58 | $7.5661 | $11.57 | -49.28% |
| December, 2026 | $7.713 | $7.113 | $11.95 | -63.03% |
Kalvista Pharmaceuticals Inc Stock (KALV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kalvista Pharmaceuticals Inc (KALV) is $4.4354, with a high forecast of $8.8502 and a low forecast of $0.0205. This indicates an -78.74% decrease from the last price of $20.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.1226 | $6.7878 | $8.8502 | -65.86% |
| February, 2027 | $7.0423 | $6.17 | $8.8374 | -66.24% |
| March, 2027 | $3.7443 | $2.5119 | $7.3847 | -82.05% |
| April, 2027 | $3.174 | $2.284 | $5.1292 | -84.78% |
| May, 2027 | $3.9136 | $1.4688 | $4.1686 | -81.24% |
| June, 2027 | $6.5557 | $3.836 | $7.6457 | -68.57% |
| July, 2027 | $5.6653 | $4.7005 | $8.2031 | -72.84% |
| August, 2027 | $4.625 | $4.5626 | $6.5602 | -77.83% |
| September, 2027 | $0.1071 | $0.2354 | $4.9298 | -99.49% |
| October, 2027 | $0.3367 | $0.0205 | $0.6167 | -98.39% |
| November, 2027 | $2.3764 | $0.2591 | $2.5964 | -88.61% |
| December, 2027 | $6.2384 | $1.7188 | $6.3684 | -70.09% |
Kalvista Pharmaceuticals Inc Stock (KALV) Price Forecast for 2028
In 2028, Kalvista Pharmaceuticals Inc (KALV) is projected to reach an average price of $4.3116, with a high projection of $8.5681 and a low estimate of $0.0551. This indicates an -79.33% fall from the last price of $20.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.6481 | $5.9808 | $8.5681 | -63.34% |
| February, 2028 | $6.1077 | $4.6553 | $7.9305 | -70.72% |
| March, 2028 | $3.2202 | $3.5402 | $6.3501 | -84.56% |
| April, 2028 | $3.0106 | $3.1654 | $2.7978 | -85.57% |
| May, 2028 | $2.9785 | $2.8009 | $2.6702 | -85.72% |
| June, 2028 | $0.5588 | $1.0938 | $1.1761 | -97.32% |
| July, 2028 | $0.0508 | $0.214 | $0.6308 | -99.76% |
| August, 2028 | $0.8371 | $0.4694 | $0.4905 | -95.99% |
| September, 2028 | $0.2725 | $0.1774 | $0.5625 | -98.69% |
| October, 2028 | $2.0022 | $0.0551 | $2.0322 | -90.40% |
| November, 2028 | $2.4942 | $1.4794 | $3.3994 | -88.04% |
| December, 2028 | $1.5839 | $1.3339 | $3.0067 | -92.41% |
Kalvista Pharmaceuticals Inc Stock (KALV) Price Forecast for 2029
The 2029 price forecast for Kalvista Pharmaceuticals Inc Stock (KALV) is $5.3121 on average, with a high prediction of $10.31 and a low estimate of $0.3094. This represents an -74.53% decrease from the previous price of $20.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.796 | $1.3663 | $3.6287 | -86.60% |
| February, 2029 | $3.7656 | $2.7184 | $4.2356 | -81.95% |
| March, 2029 | $2.6953 | $2.4853 | $4.218 | -87.08% |
| April, 2029 | $2.0449 | $1.2325 | $3.2401 | -90.20% |
| May, 2029 | $1.147 | $0.777 | $2.5923 | -94.50% |
| June, 2029 | $1.9866 | $0.3094 | $2.1466 | -90.48% |
| July, 2029 | $5.5063 | $0.6014 | $6.0013 | -73.60% |
| August, 2029 | $9.1383 | $4.4587 | $9.5783 | -56.19% |
| September, 2029 | $6.038 | $5.388 | $10.31 | -71.05% |
| October, 2029 | $5.4201 | $5.1501 | $8.2804 | -74.02% |
| November, 2029 | $5.2297 | $4.2925 | $6.048 | -74.93% |
| December, 2029 | $0.66 | $3.7871 | $6.2469 | -96.84% |
Kalvista Pharmaceuticals Inc Stock (KALV) Price Forecast for 2030
Kalvista Pharmaceuticals Inc Stock (KALV) is expected to reach an average price of $9.1544 in 2030, with a high forecast of $15.84 and a low forecast of $2.4652. This signifies an -56.12% decrease from the last price of $20.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.6559 | $2.4652 | $5.1459 | -72.89% |
| February, 2030 | $7.7566 | $5.6862 | $6.2266 | -62.82% |
| March, 2030 | $8.7373 | $8.7169 | $8.5373 | -58.11% |
| April, 2030 | $9.368 | $9.5528 | $9.0554 | -55.09% |
| May, 2030 | $13.11 | $9.8383 | $12.82 | -37.16% |
| June, 2030 | $13.07 | $13.81 | $13.17 | -37.32% |
| July, 2030 | $11.18 | $13.36 | $12.78 | -46.40% |
| August, 2030 | $6.9611 | $8.3611 | $9.6856 | -66.63% |
| September, 2030 | $8.6018 | $7.7966 | $6.7718 | -58.76% |
| October, 2030 | $8.5927 | $6.8522 | $7.2477 | -58.81% |
| November, 2030 | $16.46 | $9.8229 | $10.89 | -21.10% |
| December, 2030 | $15.83 | $16.05 | $15.84 | -24.12% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):